Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.7NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.4.1.7ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.2.80ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.2.80ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.2.80ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.80ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.80ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.80ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.2.80ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.80SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.80SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.80SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.80EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.80NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.80NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.80NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.80NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.80NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.80NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.80NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.80NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.80ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
AY.134ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
AY.134ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
AY.134ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.134ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
AY.134ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AY.134ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
AY.134ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AY.134SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.134SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.134SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.134NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.134NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.134NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.134NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19590.4Germany
AY.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.134NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.134NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.134NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2113.71Japan
AY.134ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
CZ.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
CZ.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used